when

Latest
Archive

by source

All Sources
Sources Page

department

Clinical
Regulatory
Medical Affairs
Commercial
R&D / Discovery
Biostatistics / Data
Manufacturing / CMC
Market Access

therapeutic area

Oncology
Immunology
Neuroscience
Cardiovascular
Metabolic
Rare Disease
Infectious Disease

location & type

Remote Only
US Only
California
Massachusetts
Internships
Phase 3 Roles
All Jobs →

Sign In Subscribe

pharmadog

fetch the data · sniff the signal

Discover

Jobs
News

Hubs

Topics
Patent cliff
Publications

Tools

Compare
Search
Bookmarks

Trust

About
Sources
Contact

Legal

Privacy
Terms
Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

home
jobs
news
search

Obesity · news · pharmadog

← back to Obesity

News mentioning Obesity

367 stories

Jul 21, 26Opinion: How a controversial rule could hurt the NIH’s ability to manage riskstat

Jul 21, 26Opinion: Science and the public are learning the wrong lessons from Covidstat

Jul 20, 26Opinion: My husband’s suicide shows there’s something very wrong with the U.S. insurance industrystat

Jul 20, 26STAT+: Telemedicine company touted by Novo Nordisk stressed profits over patient safety, ex-workers saystat

Jul 20, 26Opinion: It’s time to treat pandemics as threats to national securitystat

Jul 20, 26Type 1 diabetes pipeline making ‘remarkable progress’ toward insulin independencebiospace

Jul 18, 26Opinion: Beware the unintended consequences of testosterone screening for military servicemembersstat

Jul 18, 26Opinion: STAT readers on the value of primary care, obesity as a disease, and morestat

Jul 17, 26Compounders maintain a firm grip on the GLP-1 marketbiopharma dive

Jul 17, 26Zealand Pharma gets its US marketing leader from Lilly; Bexorg turns to Biohaven for CSO hireendpoints

Jul 16, 26Predicting biotech clinical trials and a new Alzheimer’s drug controversystat

Jul 16, 26Lilly to buy AtaiBeckley for $2.8B, further validating psychedelicsbiopharma dive

Jul 16, 26Chutes & Ladders—Cue lines up new CMO and research headfiercebiotech

Jul 16, 26Braveheart, Attovia, Vogenx keep IPOs ballooning with plans to compete in cardiometabolic, immunobiospace

Jul 16, 26STAT+: Kalshi comes for biopharma, with prediction markets for clinical trials and FDA approvalsstat

Jul 16, 26STAT+: Eli Lilly to acquire psychedelics-focused biotech AtaiBeckleystat

Jul 16, 26Opinion: The growing fang-to-pharmacy pipelinestat

Jul 15, 26STAT+: Celcuity’s breast cancer drug approved, its firststat

Jul 15, 26Deaths from coronary artery disease have fallen, but more progress is within reachstat

Jul 15, 26STAT+: Pharmalittle: We’re reading about a Biogen Alzheimer’s drug, skyrocketing 340B drug sales, and morestat

Jul 15, 26What to know about the parasitic diarrhea outbreakstat

Jul 15, 26STAT+: A new biotech startup tries to tackle obesity, but not in the way you might expectstat

Jul 14, 26STAT+: Akero team, backed by Fairmount, launches new immunology companystat

Jul 14, 26Opinion: It looks like your doctor and talks like your doctor. But it’s not your doctorstat

Jul 14, 2612 ideas for tackling the U.S. alcohol epidemicstat

Jul 13, 26Opinion: The shortage of forensic pathologists is hurting justice, public health, and familiesstat

Jul 13, 26Opinion: Is there a doctor on board? Yes, and airlines depend on itstat

Jul 10, 26US biotechs turn secretive as they fear competition from rising Chinese industryendpoints

Jul 10, 26STAT+: Roche ends Huntington’s gene-silencing programsstat

Jul 10, 26Pfizer appoints obesity discovery head; AI startup Xaira makes leadership adjustmentsendpoints

← prevpage 5 of 13next →